1 - 10 of 40 articles
Key PointsQuestionIs the glucocorticoid-induced tumor necrosis factor receptor–related protein agonist BMS-986156 treatment with or without nivolumab tolerable and clinically active in patients with advanced solid tumors?
FindingsIn this open-label, phase 1/2a study of 292 treated patients with...
Key PointsQuestionAre population-based quality indicators for the care of patients with cancer who have advanced disease and/or are at the end of life appropriate for use?
FindingsIn this systematic review, 288 quality indicators (260 unique), extracted from 35 references to 28 individual...
Key PointsQuestionDoes marine ω-3 fatty acid supplementation reduce risk of colorectal cancer precursors in the US general population?
FindingsIn this randomized clinical trial that included 25 871 adults, daily supplementation of marine ω-3 fatty acid, 1 g, did not reduce risk of conventional...
This phase 2 clinical trial of patients with recurrence of breast cancer in the ipsilateral breast assesses the effectiveness of partial breast reirradiation after a second lumpectomy.
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.